Swedish diabete startup Diasend merges with American competitor, starts operating under Glokoo name, which raises additional investment of SEK 70M

The new capital is from various investors, Samsung Ventures among them.

Diasends was founded in 2004 and last year had net sales of SEK 36 million, with an operating profit of 6.5 million.

Glooko has already taken in over $100 million in venture capital, while Diasend so far brought in about 25 million.

Original story